Hospital Medicine

Glomerulonephritis

Questions discussed in this category

What would be your approach to managing severe ANCA-associated vasculitis in a patient who is also septic from a bacterial infection?

1 Answer available

How would you manage a patient with CKD4 due to lupus nephritis of unknown class who develops AKI requiring hemodialysis and nephrotic range proteinuria and is found to have atrophic kidneys on imaging?

3 Answers available

How do you choose between eculizumab and ravulizumab for patients with acute kidney injury from complement mediated thrombotic microangiopathy?

1 Answer available

Would you add an SGLT2 inhibitor to augment diuresis during a hospitalization in a patient with nephrotic syndrome, an eGFR above 30 mL/min/1.73m2, and refractory hypervolemia on an intravenous loop diuretic?

1 Answer available

Papers discussed in this category

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2017 Mar-Apr

Biopsy of small kidneys: A safe and a useful guide to potentially treatable kidney disease.

Clinical journal of the American Society of Nephrology : CJASN, 2017 May 04

Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis.

Journal of immunological methods, 2020 Dec 13

Monitoring Ravulizumab effect on complement assays.

Kidney international reports, 2021 Mar 24

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults.

Kidney international, 2020 Mar 06

The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.

Hospital Medicine

Glomerulonephritis

Questions discussed in this category

Papers discussed in this category

Related Topics in Hospital Medicine